Artelo Biosciences to Participate in BIO Digital and The Investor Summit Conferences

LA JOLLA, Calif., June 03, 2020 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system and related pathways, announced today that it will be participating in two upcoming virtual conferences.

Click to view original post